| UniProt ID | ACATN_HUMAN | |
|---|---|---|
| UniProt AC | O00400 | |
| Protein Name | Acetyl-coenzyme A transporter 1 | |
| Gene Name | SLC33A1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 549 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
| Protein Description | Probable acetyl-CoA transporter necessary for O-acetylation of gangliosides. [PubMed: 9096318 Negatively regulates BMP signaling] | |
| Protein Sequence | MSPTISHKDSSRQRRPGNFSHSLDMKSGPLPPGGWDDSHLDSAGREGDREALLGDTGTGDFLKAPQSFRAELSSILLLLFLYVLQGIPLGLAGSIPLILQSKNVSYTDQAFFSFVFWPFSLKLLWAPLVDAVYVKNFGRRKSWLVPTQYILGLFMIYLSTQVDRLLGNTDDRTPDVIALTVAFFLFEFLAATQDIAVDGWALTMLSRENVGYASTCNSVGQTAGYFLGNVLFLALESADFCNKYLRFQPQPRGIVTLSDFLFFWGTVFLITTTLVALLKKENEVSVVKEETQGITDTYKLLFAIIKMPAVLTFCLLILTAKIGFSAADAVTGLKLVEEGVPKEHLALLAVPMVPLQIILPLIISKYTAGPQPLNTFYKAMPYRLLLGLEYALLVWWTPKVEHQGGFPIYYYIVVLLSYALHQVTVYSMYVSIMAFNAKVSDPLIGGTYMTLLNTVSNLGGNWPSTVALWLVDPLTVKECVGASNQNCRTPDAVELCKKLGGSCVTALDGYYVESIICVFIGFGWWFFLGPKFKKLQDEGSSSWKCKRNN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSPTISHKD ------CCCCCCCCC | 30.65 | 29255136 | |
| 4 | Phosphorylation | ----MSPTISHKDSS ----CCCCCCCCCCC | 28.01 | 29514088 | |
| 6 | Phosphorylation | --MSPTISHKDSSRQ --CCCCCCCCCCCCC | 27.28 | 25404012 | |
| 20 | Phosphorylation | QRRPGNFSHSLDMKS CCCCCCCCCCCCCCC | 19.03 | 21406692 | |
| 22 | Phosphorylation | RPGNFSHSLDMKSGP CCCCCCCCCCCCCCC | 25.51 | 25159151 | |
| 38 | Phosphorylation | PPGGWDDSHLDSAGR CCCCCCHHHHHCCCC | 24.39 | 28555341 | |
| 42 | Phosphorylation | WDDSHLDSAGREGDR CCHHHHHCCCCCCCH | 38.70 | - | |
| 63 | Ubiquitination | TGTGDFLKAPQSFRA CCCCHHHHCCHHHHH | 59.00 | 21906983 | |
| 103 | N-linked_Glycosylation | PLILQSKNVSYTDQA HEEEECCCCCCCCHH | 32.96 | UniProtKB CARBOHYD | |
| 133 | Phosphorylation | APLVDAVYVKNFGRR HHHCCEEEEECCCCC | 13.87 | - | |
| 135 | Ubiquitination | LVDAVYVKNFGRRKS HCCEEEEECCCCCCC | 28.95 | 21963094 | |
| 288 | Ubiquitination | ENEVSVVKEETQGIT HCCCEEEECCCCCCC | 47.91 | 29967540 | |
| 325 | Phosphorylation | LTAKIGFSAADAVTG HHHHHCCCHHHHHHC | 19.82 | - | |
| 331 | Phosphorylation | FSAADAVTGLKLVEE CCHHHHHHCCCHHHC | 38.22 | - | |
| 364 | Phosphorylation | IILPLIISKYTAGPQ HHHHHHHHHCCCCCC | 16.77 | - | |
| 366 | Phosphorylation | LPLIISKYTAGPQPL HHHHHHHCCCCCCCC | 8.60 | 23663014 | |
| 367 | Phosphorylation | PLIISKYTAGPQPLN HHHHHHCCCCCCCCH | 28.95 | 23663014 | |
| 375 | Phosphorylation | AGPQPLNTFYKAMPY CCCCCCHHHHHHHHH | 35.70 | 23663014 | |
| 377 | Phosphorylation | PQPLNTFYKAMPYRL CCCCHHHHHHHHHHH | 8.87 | 23663014 | |
| 378 | Ubiquitination | QPLNTFYKAMPYRLL CCCHHHHHHHHHHHH | 33.74 | - | |
| 382 | Phosphorylation | TFYKAMPYRLLLGLE HHHHHHHHHHHHHHH | 10.78 | 23663014 | |
| 496 | S-palmitoylation | TPDAVELCKKLGGSC CHHHHHHHHHHCCCH | 2.01 | 29575903 | |
| 497 | Ubiquitination | PDAVELCKKLGGSCV HHHHHHHHHHCCCHH | 64.75 | 29967540 | |
| 498 | Ubiquitination | DAVELCKKLGGSCVT HHHHHHHHHCCCHHH | 51.90 | - | |
| 534 | Ubiquitination | FLGPKFKKLQDEGSS HHCHHHHHHCCCCCC | 55.29 | 29967540 | |
| 541 | Phosphorylation | KLQDEGSSSWKCKRN HHCCCCCCCCCCCCC | 51.58 | - | |
| 544 | Ubiquitination | DEGSSSWKCKRNN-- CCCCCCCCCCCCC-- | 31.65 | 29967540 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ACATN_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACATN_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACATN_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00266 | Hereditary spastic paraplegia (SPG) | |||||
| OMIM Disease | ||||||
| 612539 | Spastic paraplegia 42, autosomal dominant (SPG42) | |||||
| 614482 | Congenital cataracts, hearing loss, and neurodegeneration (CCHLND) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASSSPECTROMETRY. | |